Goldman Sachs’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-125,100
| Closed | -$786K | – | 5922 |
|
|
2022
Q4 | $786K | Hold |
125,100
| – | – | ﹤0.01% | 4583 |
|
|
2022
Q3 | $862K | Hold |
125,100
| – | – | ﹤0.01% | 4615 |
|
|
2022
Q2 | $1.05M | Buy |
+125,100
| New | +$1.75M | ﹤0.01% | 4577 |
|
|
2020
Q1 | – | Sell |
-430,000
| Closed | -$12.9M | – | 5209 |
|
|
2019
Q4 | $12.9M | Hold |
430,000
| – | – | ﹤0.01% | 2243 |
|
|
2019
Q3 | $9.4M | Hold |
430,000
| – | – | ﹤0.01% | 2372 |
|
|
2019
Q2 | $10.8M | Sell |
430,000
-101,100
| -19% | -$2.4M | ﹤0.01% | 2297 |
|
|
2019
Q1 | $13.1M | Buy |
531,100
+10,400
| +2% | +$248K | ﹤0.01% | 2207 |
|
|
2018
Q4 | $9.62M | Sell |
520,700
-449,800
| -46% | -$10.7M | ﹤0.01% | 2374 |
|
|
2018
Q3 | $24.9M | Sell |
970,500
-125,200
| -11% | -$2.87M | 0.01% | 1760 |
|
|
2018
Q2 | $25.5M | Sell |
1,095,700
-431,300
| -28% | -$8.92M | 0.01% | 1708 |
|
|
2018
Q1 | $24.3M | Sell |
1,527,000
-150,500
| -9% | -$2.8M | 0.01% | 1692 |
|
|
2017
Q4 | $34.9M | Sell |
1,677,500
-295,900
| -15% | -$4.69M | 0.01% | 1546 |
|
|
2017
Q3 | $28.3M | Sell |
1,973,400
-154,300
| -7% | -$2.33M | 0.01% | 1715 |
|
|
2017
Q2 | $36.8M | Buy |
2,127,700
+411,900
| +24% | +$4.94M | 0.01% | 1455 |
|
|
2017
Q1 | $18.9M | Buy |
1,715,800
+17,600
| +1% | +$242K | 0.01% | 1924 |
|
|
2016
Q4 | $24.7M | Buy |
1,698,200
+793,100
| +88% | +$14.5M | 0.01% | 1820 |
|
|
2016
Q3 | $22.2M | Buy |
905,100
+266,400
| +42% | +$6.89M | 0.01% | 1811 |
|
|
2016
Q2 | $12.9M | Sell |
638,700
-852,500
| -57% | -$24.1M | ﹤0.01% | 2124 |
|
|
2016
Q1 | $39.2M | Buy |
1,491,200
+154,200
| +12% | +$11.4M | 0.01% | 1245 |
|
|
2015
Q4 | $136M | Buy |
1,337,000
+702,400
| +111% | +$78.9M | 0.04% | 513 |
|
|
2015
Q3 | $113M | Sell |
634,600
-156,700
| -20% | -$36.5M | 0.04% | 548 |
|
|
2015
Q2 | $176M | Sell |
791,300
-267,400
| -25% | -$59.3M | 0.05% | 388 |
|
|
2015
Q1 | $210M | Sell |
1,058,700
-417,000
| -28% | -$74M | 0.07% | 339 |
|
|
2014
Q4 | $211M | Buy |
1,475,700
+539,600
| +58% | +$72.6M | 0.07% | 345 |
|
|
2014
Q3 | $123M | Buy |
936,100
+83,000
| +10% | +$9.89M | 0.04% | 541 |
|
|
2014
Q2 | $108M | Sell |
853,100
-48,300
| -5% | -$6.16M | 0.03% | 630 |
|
|
2014
Q1 | $119M | Buy |
901,400
+758,000
| +529% | +$104M | 0.04% | 546 |
|
|
2013
Q4 | $16.8M | Sell |
143,400
-30,400
| -17% | -$3.33M | 0.01% | 1888 |
|
|
2013
Q3 | $18.1M | Buy |
173,800
+31,200
| +22% | +$3.04M | 0.01% | 1705 |
|
|
2013
Q2 | $12.3M | Buy |
+142,600
| New | +$11.2M | ﹤0.01% | 1920 |
|
Other funds holding BHC
PC
GAM
VCM
MP
KKRC
Goldman Sachs's BHC Position: Q1 2026 in Review
Goldman Sachs increased its Bausch Health (BHC) stake by 1.3% in Q1 2026, buying an estimated $385K and bringing the position to 5,207,966 shares worth $28.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2116.
Goldman Sachs first reported a position in BHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $591M in Q4 2015. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.
- Goldman Sachs held 5,207,966 shares of Bausch Health worth $28.1M as of Q1 2026.
- Goldman Sachs bought 64,325 Bausch Health shares in Q1 2026, an estimated $385K.
- Bausch Health made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2116 holding.
- Goldman Sachs first reported a position in Bausch Health in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Bausch Health position peaked at $591M in Q4 2015.
- 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.